Hongqi Shi

429 total citations
23 papers, 347 citations indexed

About

Hongqi Shi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongqi Shi has authored 23 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongqi Shi's work include Sarcoma Diagnosis and Treatment (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Hongqi Shi is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Hongqi Shi collaborates with scholars based in China and United Kingdom. Hongqi Shi's co-authors include Yunfeng Shan, Qiyu Zhang, Zhengping Yu, Qiyu Zhang, Yuan‐Lan Huang, Bicheng Chen, Yunpeng Sun, Mengtao Zhou, Huanhuan Wu and Xian Shen and has published in prestigious journals such as RSC Advances, BMC Cancer and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Hongqi Shi

23 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongqi Shi China 9 191 109 97 63 53 23 347
Manqing Cao China 11 421 2.2× 309 2.8× 125 1.3× 50 0.8× 57 1.1× 17 601
Chengdong Qin China 10 358 1.9× 303 2.8× 105 1.1× 35 0.6× 45 0.8× 19 545
Carolin Czauderna Germany 12 120 0.6× 91 0.8× 126 1.3× 134 2.1× 73 1.4× 25 358
Yuandeng Luo China 8 184 1.0× 90 0.8× 67 0.7× 13 0.2× 53 1.0× 12 285
Yue Shao China 12 145 0.8× 90 0.8× 104 1.1× 28 0.4× 65 1.2× 26 373
Cheng Tang China 15 196 1.0× 117 1.1× 164 1.7× 30 0.5× 158 3.0× 40 516
Junming Xu China 12 239 1.3× 140 1.3× 97 1.0× 20 0.3× 74 1.4× 27 402
Haibo Mou China 10 128 0.7× 71 0.7× 117 1.2× 12 0.2× 60 1.1× 29 362

Countries citing papers authored by Hongqi Shi

Since Specialization
Citations

This map shows the geographic impact of Hongqi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongqi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongqi Shi more than expected).

Fields of papers citing papers by Hongqi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongqi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongqi Shi. The network helps show where Hongqi Shi may publish in the future.

Co-authorship network of co-authors of Hongqi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Hongqi Shi. A scholar is included among the top collaborators of Hongqi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongqi Shi. Hongqi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shi, Hongqi, et al.. (2024). Efficacy of brachytherapy versus radical prostatectomy for localized prostate cancer–propensity score-matched comparison. BMC Cancer. 24(1). 1177–1177. 1 indexed citations
3.
Huang, Weiguo, et al.. (2020). Development of cancer prognostic signature based on pan-cancer proteomics. Bioengineered. 11(1). 1368–1381. 6 indexed citations
4.
Chen, Zhenwei, et al.. (2020). Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature. Diagnostic Pathology. 15(1). 15–15. 18 indexed citations
5.
Chen, Jiajun, et al.. (2020). Applied anatomy of pelvic lymph nodes and its clinical significance for prostate cancer:a single-center cadaveric study. BMC Cancer. 20(1). 330–330. 7 indexed citations
6.
Hu, Yanting, Lixia Wang, Hongqi Shi, & Bin Hu. (2020). Endometrial polyp-like perivascular epithelioid cell neoplasm associated with TFE3 translocation: report of one case.. PubMed. 13(3). 543–549. 5 indexed citations
7.
Shi, Hongqi, et al.. (2018). Application of pubovesical complex preserving technique during laparoscopic radical prostatectomy. Zhonghua miniao waike zazhi. 39(7). 515–521. 2 indexed citations
8.
Sun, Yunpeng, Qiandong Zhu, Mengtao Zhou, et al.. (2018). Restoration of miRNA‑148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β‑catenin signaling pathway via downregulating maternally expressed gene‑3. Experimental and Therapeutic Medicine. 17(1). 639–648. 16 indexed citations
9.
Chen, Zhenwei, et al.. (2018). Primary pericardial primitive neuroectodermal tumor: a case report and review of literature.. PubMed. 11(4). 2155–2159. 2 indexed citations
10.
11.
Wang, Yi, Haitao Yu, Yunfeng Shan, et al.. (2016). EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway. Journal of Experimental & Clinical Cancer Research. 35(1). 65–65. 25 indexed citations
12.
Sun, Yunpeng, Fuxiang Yu, Wenjun Yang, et al.. (2016). Discovery of a novel human lactate dehydrogenase A (LDHA) inhibitor as an anti-proliferation agent against MIA PaCa-2 pancreatic cancer cells. RSC Advances. 6(28). 23218–23222. 4 indexed citations
13.
Wu, Huanhuan, et al.. (2016). Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway. OncoTargets and Therapy. 9. 2845–2845. 42 indexed citations
14.
Chen, Zhenwei, et al.. (2015). [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].. PubMed. 44(5). 320–2. 4 indexed citations
15.
Shi, Hongqi, et al.. (2015). [Clinicopathologic analysis of 254 cases of papillary thyroid microcarcinoma].. PubMed. 44(4). 258–61. 4 indexed citations
16.
He, Bin, et al.. (2014). MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking. Molecular Medicine Reports. 11(3). 2355–2359. 33 indexed citations
17.
He, Bin, Kate Huang, Peng Li, et al.. (2014). Undifferentiated embryonal liver sarcoma in childhood: A case report. Oncology Letters. 8(3). 1127–1132. 2 indexed citations
18.
Chen, Zhenkun, Kate Huang, Peng Li, et al.. (2013). Decreased Expression of LKB1 Correlates with Poor Prognosis in Hepatocellular Carcinoma Patients Undergoing Hepatectomy. Asian Pacific Journal of Cancer Prevention. 14(3). 1985–1988. 24 indexed citations
19.
Shan, Yunfeng, Yuan‐Lan Huang, Bicheng Chen, et al.. (2010). Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status. Medical Oncology. 28(4). 1012–1016. 79 indexed citations
20.
Shan, Yunfeng, et al.. (2009). Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells. Acta Pharmacologica Sinica. 30(11). 1537–1542. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manqing Cao Breakdown of academic impact, for papers by Chengdong Qin Breakdown of academic impact, for papers by Carolin Czauderna Breakdown of academic impact, for papers by Yuandeng Luo Breakdown of academic impact, for papers by Yue Shao Breakdown of academic impact, for papers by Cheng Tang Breakdown of academic impact, for papers by Junming Xu Breakdown of academic impact, for papers by Haibo Mou
Rankless by CCL
2026